HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Washington University School of Medicine
University of Texas Southwestern Medical Center
University of Alberta
Memorial Sloan Kettering Cancer Center
Shiraz University of Medical Sciences
Universidad de Granada
Rutgers, The State University of New Jersey
SWOG Cancer Research Network
Tanta University
Washington University School of Medicine
Abramson Cancer Center at Penn Medicine
University of Virginia
Norwegian University of Science and Technology
Women's College Hospital
University of Sao Paulo General Hospital
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Instituto Nacional de Cardiologia Ignacio Chavez
Silesian Centre for Heart Diseases
Cedars-Sinai Medical Center
Erasmus Medical Center
University of Hull
Nova Scotia Health Authority
Technical University of Madrid
Fondazione IRCCS Policlinico San Matteo di Pavia
Institut de Radioprotection et de Surete Nucleaire
University of Sydney
National Cheng-Kung University Hospital
Wake Forest University Health Sciences
Hospital Clinico Universitario de Santiago
University Hospital, Akershus
Insel Gruppe AG, University Hospital Bern
Humanitas Hospital, Italy
Institut de cancérologie Strasbourg Europe
Mayo Clinic
Heinrich-Heine University, Duesseldorf
D'Or Institute for Research and Education
Azienda Ospedaliero-Universitaria Careggi
GO fit Lab- Ingesport
University of South Florida
Horus University
Samsung Medical Center
University of British Columbia
Cedars-Sinai Medical Center
Henry Ford Health System
Karolinska University Hospital
University of Sao Paulo
AHS Cancer Control Alberta
AHS Cancer Control Alberta
Hellenic Oncology Research Group
Catharina Ziekenhuis Eindhoven